Curative Biotechnology Stock Probability of Future Stock Price Finishing Under 0.00
| CUBT Stock | USD 0.01 0.0001 1.15% |
Curative |
Curative Biotechnology Target Price Odds to finish below 0.00
The tendency of Curative Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 0.00 or more in 90 days |
| 0.01 | 90 days | 0.00 | near 1 |
Based on a normal probability distribution, the odds of Curative Biotechnology to drop to $ 0.00 or more in 90 days from now is near 1 (This Curative Biotechnology probability density function shows the probability of Curative Stock to fall within a particular range of prices over 90 days) . Probability of Curative Biotechnology price to stay between $ 0.00 and its current price of $0.0088 at the end of the 90-day period is about 19.56 .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.19 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Curative Biotechnology will likely underperform. Additionally Curative Biotechnology has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Curative Biotechnology Price Density |
| Price |
Predictive Modules for Curative Biotechnology
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Curative Biotechnology. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Curative Biotechnology Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Curative Biotechnology is not an exception. The market had few large corrections towards the Curative Biotechnology's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Curative Biotechnology, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Curative Biotechnology within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.06 | |
β | Beta against Dow Jones | 2.19 | |
σ | Overall volatility | 0 | |
Ir | Information ratio | 0.01 |
Curative Biotechnology Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Curative Biotechnology for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Curative Biotechnology can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Curative Biotechnology had very high historical volatility over the last 90 days | |
| Curative Biotechnology has some characteristics of a very speculative penny stock | |
| Curative Biotechnology has a very high chance of going through financial distress in the upcoming years | |
| Curative Biotechnology currently holds 2.26 M in liabilities with Debt to Equity (D/E) ratio of 6.6, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Curative Biotechnology has a current ratio of 0.1, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Curative Biotechnology's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 132.32 K. Net Loss for the year was (3.96 M) with profit before overhead, payroll, taxes, and interest of 100.21 K. | |
| Curative Biotechnology currently holds about 126.85 K in cash with (486.58 K) of positive cash flow from operations. | |
| Curative Biotechnology has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635 - The Manila Times |
Curative Biotechnology Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Curative Stock often depends not only on the future outlook of the current and potential Curative Biotechnology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Curative Biotechnology's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 662.2 M | |
| Cash And Short Term Investments | 56.4 K |
Curative Biotechnology Technical Analysis
Curative Biotechnology's future price can be derived by breaking down and analyzing its technical indicators over time. Curative Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Curative Biotechnology. In general, you should focus on analyzing Curative Stock price patterns and their correlations with different microeconomic environments and drivers.
Curative Biotechnology Predictive Forecast Models
Curative Biotechnology's time-series forecasting models is one of many Curative Biotechnology's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Curative Biotechnology's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Curative Biotechnology
Checking the ongoing alerts about Curative Biotechnology for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Curative Biotechnology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Curative Biotechnology had very high historical volatility over the last 90 days | |
| Curative Biotechnology has some characteristics of a very speculative penny stock | |
| Curative Biotechnology has a very high chance of going through financial distress in the upcoming years | |
| Curative Biotechnology currently holds 2.26 M in liabilities with Debt to Equity (D/E) ratio of 6.6, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Curative Biotechnology has a current ratio of 0.1, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Curative Biotechnology's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 132.32 K. Net Loss for the year was (3.96 M) with profit before overhead, payroll, taxes, and interest of 100.21 K. | |
| Curative Biotechnology currently holds about 126.85 K in cash with (486.58 K) of positive cash flow from operations. | |
| Curative Biotechnology has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635 - The Manila Times |
Additional Tools for Curative Stock Analysis
When running Curative Biotechnology's price analysis, check to measure Curative Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curative Biotechnology is operating at the current time. Most of Curative Biotechnology's value examination focuses on studying past and present price action to predict the probability of Curative Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Curative Biotechnology's price. Additionally, you may evaluate how the addition of Curative Biotechnology to your portfolios can decrease your overall portfolio volatility.